Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2021  |  Volume : 34  |  Issue : 1  |  Page : 56-60

The value of calcium and high-sensitivity C-reactive protein serum levels in psoriatic patients

1 Department of Dermatology, Andrology and STDs, Faculty of Medicine, Menoufia University, Menoufia, Egypt
2 Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Menoufia University, Menoufia, Egypt
3 Department of Dermatology, Ministry of Health, Menoufia, Egypt

Correspondence Address:
Shaimaa B El Hagary
Shiben Elkome, Menoufia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/mmj.mmj_227_19

Rights and Permissions

Objective The aim was to evaluate the level of serum calcium and the serum level of high-sensitivity C-reactive protein (hsCRP) in patients with psoriasis. Background Psoriasis is a systemic chronic inflammatory disease of the skin with associated comorbidity. The most detrimental aspect of psoriasis is the concurrent physical comorbidities, such as cardiovascular disease, obesity, diabetes, metabolic syndrome, inflammatory bowel disease, and psoriatic arthritis that contribute to decreased longevity. Psoriasis is one of the skin diseases that have been found to show disturbance in systemic calcium metabolism. CRP is one of the acute-phase reactant proteins, and its blood level increases during inflammatory reactions. There is a link between the concentration of CRP and cardiovascular disease development in psoriatic patients. Patients and methods Psoriatic patients (n = 40) and age, sex-matched, and BMI-matched healthy controls (n = 40) were enrolled. Serum levels of hsCRP were measured by enzyme-linked immunosorbent assay, and assessment of serum calcium was done using enzymatic colorimetric technique. Results Serum calcium (P < 0.001) and serum hsCRP (P < 0.001) showed significant differences compared with controls. Conclusion Several biomarkers are altered in patients with psoriasis. In particular, decrease in serum calcium and increase in serum hsCRP could be of interest for further studies. A longitudinal observation study on levels of these biomarkers in response to treatment as well as a correlation of these markers with the development of concomitant diseases in patients with moderate-to-severe psoriasis should be initiated.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded40    
    Comments [Add]    

Recommend this journal